Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 12, Number 6, February 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Editorial [Hot Topic: Drug Targets in Alzheimer's Disease (Executive Editors: G. Munch and G. Stuchbury)]
pp. 659-660(2)
Authors: Munch, Gerald; Stuchbury, Grant

γ-Secretase as a Therapeutic Target for Treatment of Alzheimer's Disease
pp. 661-670(10)
Authors: Tomita, Taisuke; Iwatsubo, Takeshi

Reduction of Aβ Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for Aβ Production Inhibitors
pp. 671-676(6)
Authors: Mouedden, Mohammed E.; Vandermeeren, Marc; Meert, Theo; Mercken, Marc

Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimer's Disease Pyramidal Neurons
pp. 677-684(8)
Authors: D'Andrea, Michael R.; Nagele, Robert G.

Antigonadotropins: A Novel Strategy to Halt Alzheimer's Disease Progression
pp. 685-690(6)
Authors: Gregory, Christopher W.; Atwood, Craig S.; Smith, Mark A.; Bowen, Richard L.

The Cell Cycle and Hormonal Fluxes in Alzheimer Disease: A Novel Therapeutic Target
pp. 691-697(7)
Authors: Webber, Kate M.; Casadesus, Gemma; Zhu, Xiongwei; Obrenovich, Mark E.; Atwood, Craig S.; Perry, George; Bowen, Richard L.; Smith, Mark A.

Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimer's Disease
pp. 699-704(6)
Authors: Hajieva, P.; Behl, C.

Neuroprotective Therapies for Alzheimer's Disease
pp. 705-717(13)
Authors: Huber, Anke; Stuchbury, Grant; Burkle, Alexander; Burnell, Jim; Munch, Gerald

Brain Inflammation, Cholesterol, and Glutamate as Interconnected Participants in the Pathology of Alzheimer's Disease
pp. 719-738(20)
Authors: Ringheim, G. E.; Szczepanik, A. M.

Mitochondria: A Target for Neuroprotective Interventions in Cerebral Ischemia-Reperfusion
pp. 739-757(19)
Authors: Christophe, Morin; Nicolas, Simon

Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
pp. 759-772(14)
Author: Maccarrone, Mauro

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A